Global & Turkiye Laparoscopic Devices Market to 2031

The laparoscopic devices market in Turkiye is experiencing strong growth, supported by the country’s advanced healthcare infrastructure, considerable investments in medical technology, and a flourishing medical tourism industry. The adoption of minimally invasive surgery (MIS) techniques is expanding across numerous specialties, driven by benefits such as shorter recovery periods and better patient outcomes. Turkiye has become a key destination for bariatric surgery, mirroring the global increase in obesity rates. In 2023, the nation contributed to a substantial number of bariatric procedures worldwide, with over 157,000 sleeve gastrectomies and more than 63,000 Roux-en-Y gastric bypass (RYGB) surgeries performed globally, many of which were laparoscopic and involved patients traveling to Turkiye for specialized care. This growing patient demand continues to fuel the laparoscopic devices market.

Minimally invasive methods are extensively used in general surgery as well. A 2024 review of Turkish general surgery clinical trials listed on ClinicalTrials.gov showed that laparoscopic surgery represented 3.5% of the general surgery studies, with bariatric and hepatopancreatic biliary surgeries featuring significant laparoscopic components at 9.3% and 17.4%, respectively. According to data from the Turkish Ministry of Health, of 103,387 cholecystectomies performed within a year, 98.9% (102,294) were completed laparoscopically, with a minimal 1.1% conversion rate to open surgery, highlighting widespread adoption and high success rates. Laparoscopy is also becoming more prominent in colorectal surgeries, frequently evaluated alongside robotic techniques. A meta-analysis published in December 2024 compared robotic and laparoscopic colon cancer surgeries and demonstrated the active involvement of Turkish surgeons in advanced minimally invasive colorectal procedures. Additionally, data from the Turkish Society of Colon and Rectal Surgery (2025) showed that nearly half of 158 lower rectal adenocarcinoma cases were treated laparoscopically, with a small proportion undergoing robotic surgery and a 5.9% conversion rate from laparoscopic to open surgery, underscoring laparoscopy’s important role in colorectal cancer care.

In gynecology, laparoscopic technology is widely employed. Research such as the 2024 study on the abdominal compliance index’s effect on postoperative pain after laparoscopic gynecologic procedures reflects ongoing clinical interest. Turkiye actively supports global guidelines for adhesion prevention in gynecological laparoscopy (published in 2023), emphasizing precise surgical techniques to enhance patient outcomes. The country’s medical tourism sector significantly drives laparoscopic device adoption, attracting international patients seeking affordable, high-quality care. Diagnostic laparoscopy, for example, is used effectively in Turkiye to diagnose conditions like endometriosis with a reported accuracy of 95%, at costs around US$4,000, drawing patients from nations including the UK. Esteemed Turkish surgeons with extensive laparoscopic experience bolster the country’s reputation as a center for advanced minimally invasive surgery. Furthermore, innovations such as the “Endoprotector,” a device designed to prevent contamination during minimally invasive procedures and currently under patent application in Turkiye as of 2024, illustrate the nation’s contributions to advancing laparoscopic surgery technology.